Added to YB: 2026-09-28
Pitch date: 2026-09-23
TEM [bullish]
Tempus AI, Inc.
+12.31%
current return
Author Info
Stock Pursuit researches domestic deep value equities below net cash, net current asset value or net tangible assets. Sign up for the newsletter.
Company Info
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician’s desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.
Market Cap
$14.8B
Pitch Price
$75.69
Price Target
N/A
Dividend
N/A
EV/EBITDA
-86.13
P/E
-57.36
EV/Sales
10.80
Sector
Life Sciences Tools and Services
Category
growth
Tempus AI: Winning In Pharma's AI Buildout
TEM: Tempus AI supplies clinical and molecular data for pharma’s AI buildout, monetizing diagnostics first and then licensing the resulting data at high margins; Insights revenue rose 36% year over year in Q2. Management guides to $1.6B of 2026 revenue and $65M of positive EBITDA, with approved xT CDx expected to add $85M annually from 2027. The valuation is far from cheap at 8.75x full-year revenue, while Ambry-related lawsuits test a novel consent question.
Read full article (5 min)